Top Management Presentation Financial Results for 2Q FY2014 DAIICHI SANKYO COMPANY, LIMITED Joji Nakayama President and CEO Glenn Gormley, MD, PhD Senior Executive Officer and Global Head of R&D 1/59 Financial Results for 2Q FY2014(PDF 645 KB) Edoxaban in Atrial Fibrillation(PDF 461 KB)